References
- Adcock I. M., Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol 2001; 79: 376–384, [INFOTRIEVE], [CSA]
- Aihara M., Aihara Y., Takahashi Y., Nakajima H. Effects of liposteroid on skin lesions in autoimmune MRLlpr/lpr mice. J. Dermatol. Sci 1997; 16: 45–51, [INFOTRIEVE], [CSA], [CROSSREF]
- Amsterdam A., Tajima K., Sasson R. Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action. Biochem. Pharmacol 2002; 64: 843–850, [INFOTRIEVE], [CSA], [CROSSREF]
- Badruddoja M. A., Krouwer H. G., Rand S. D., Rebro K. J., Pathak A. P., Schmainda K. M. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro-oncol 2003; 5: 235–243, [INFOTRIEVE], [CSA], [CROSSREF]
- Banciu M., Schiffelers R. M., Fens M. H., Metselaar J. M., Storm G. Anti-angiogenic effects of liposomal prednisolone phosphate on B16 melanoma in mice. J. Contr. Rel 2006, (in press)[CSA]
- Bonanomi M. H., Velvart M., Stimpel M., Roos K. M., Fehr K., Weder H. G. Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis. Rheumatol. Int 1987a; 7: 203–212, [INFOTRIEVE], [CSA], [CROSSREF]
- Bonanomi M. H., Velvart M., Weder H. G. Fate of different kinds of liposomes containing dexamethasone palmitate after intra-articular injection into rabbit joints. J. Microencapsul 1987b; 4: 189–200, [INFOTRIEVE], [CSA]
- Brusaferri F., Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J. Neurol 2000; 247: 435–442, [INFOTRIEVE], [CSA], [CROSSREF]
- Buckingham J. C. Glucocorticoids: exemplars of multi-tasking. Br. J. Pharmacol 2006; 147(Suppl 1)S258–S268, [INFOTRIEVE], [CSA], [CROSSREF]
- Buttgereit F., Burmester G. R., Lipworth B. J. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 2005; 365: 801–803, [INFOTRIEVE], [CSA]
- Buttgereit F., Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 2002; 67: 529–534, [INFOTRIEVE], [CSA], [CROSSREF]
- Buttgereit F., Straub R. H., Wehling M., Burmester G. R. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum 2004; 50: 3408–3417, [INFOTRIEVE], [CSA], [CROSSREF]
- Crum R., Szabo S., Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230: 1375–1378, [INFOTRIEVE], [CSA]
- Gross J., Azizkhan R. G., Biswas C., Bruns R. R., Hsieh D. S., Folkman J. Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc. Natl. Acad. Sci. USA 1981; 78: 1176–1180, [INFOTRIEVE], [CSA], [CROSSREF]
- Keegan B. M., Noseworthy J. H. Multiple sclerosis. Annu. Rev. Med 2002; 53: 285–302, [INFOTRIEVE], [CSA], [CROSSREF]
- Koning G. A., Schiffelers R. M., Wauben M. H., Kok R. J., Mastrobattista E., Molema G., Ten Hagen T. L., Storm G. Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis. Arthritis Rheum 2006; 54: 1198–1208, [INFOTRIEVE], [CSA], [CROSSREF]
- Korting H. C., Zienicke H., Schafer-Korting M., Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur. J. Clin. Pharmacol 1990; 39: 349–351, [INFOTRIEVE], [CSA], [CROSSREF]
- Leis H., Page A., Ramirez A., Bravo A., Segrelles C., Paramio J., Barettino D., Jorcano J. L., Perez P. Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway. Mol. Endocrinol 2004; 18: 303–311, [INFOTRIEVE], [CSA], [CROSSREF]
- Liao J., Hayashi K., Horikoshi S., Ushijima H., Kimura J., Tomino Y. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice. Nephron 2001; 89: 194–200, [INFOTRIEVE], [CSA], [CROSSREF]
- Lopez-Garcia F., Vazquez-Auton J. M., Gil F., Latoore R., Moreno F., Villalain J., Gomez-Fernandez J. C. Intra-articular therapy of experimental arthritis with a derivative of triamcinolone acetonide incorporated in liposomes. J. Pharm. Pharmacol 1993; 45: 576–578, [INFOTRIEVE], [CSA]
- Love W. G., Amos N., Kellaway I. W., Williams B. D. Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis. Ann. Rheum. Dis 1990; 49: 611–614, [INFOTRIEVE], [CSA]
- Maeda H., Sawa T., Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control Release 2001; 74: 47–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Metselaar J. M., van den Berg W. B., Holthuysen A. E., Wauben M. H., Storm G., van Lent P. L. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis 2004; 63: 348–353, [INFOTRIEVE], [CSA], [CROSSREF]
- Metselaar J. M., Wauben M. H., Boerman O. C., Van Lent P. L., Storm G. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis. Cell. Mol. Biol. Lett 2002; 7: 291–292, [INFOTRIEVE], [CSA]
- Metselaar J. M., Wauben M. H., Wagenaar-Hilbers J. P., Boerman O. C., Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 2003; 48: 2059–2066, [INFOTRIEVE], [CSA], [CROSSREF]
- Mezei M., Gulasekharam V. Liposomes—a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980; 26: 1473–147, [INFOTRIEVE], [CSA], [CROSSREF]
- Mezei M., Gulasekharam V. Liposomes—a selective drug delivery system for the topical route of administration: gel dosage form. J. Pharm. Pharmacol 1982; 34: 473–474, [INFOTRIEVE], [CSA]
- Rousseau V., Denizot B., Le Jeune J. J., Jallet P. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis. Exp. Brain Res 1999; 125: 255–264, [INFOTRIEVE], [CSA], [CROSSREF]
- Schiffelers R. M., Metselaar J. M., Fens M. H., Janssen A. P., Molema G., Storm G. Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice. Neoplasia 2005; 7: 118–127, [INFOTRIEVE], [CSA], [CROSSREF]
- Schmidt J., Metselaar J. M., Wauben M. H., Toyka K. V., Storm G., Gold R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 2003; 126: 1895–1904, [INFOTRIEVE], [CSA], [CROSSREF]
- Smoak K. A., Cidlowski J. A. Mechanisms of glucocorticoid receptor signaling during inflammation. Mech. Ageing Dev 2004; 125: 697–706, [INFOTRIEVE], [CSA], [CROSSREF]
- Taniguchi K., Itakura K., Yamazawa N., Morisaki K., Hayashi S., Yamada Y. Efficacy of a liposome preparation of anti-inflammatory steroid as an ocular drug-delivery system. J. Pharmacobiodyn 1988; 11: 39–46, [INFOTRIEVE], [CSA]
- Wassenberg S., Rau R., Steinfeld P., Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2005; 52: 3371–3380, [INFOTRIEVE], [CSA], [CROSSREF]
- Wohlrab W., Lasch J. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion. Dermatol. Monatsschr 1989; 175: 348–352, [INFOTRIEVE], [CSA]
- Wolff J. E., Guerin C., Laterra J., Bressler J., Indurti R. R., Brem H., Goldstein G. W. Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 1993; 604: 79–85, [INFOTRIEVE], [CSA], [CROSSREF]